Adherence Patterns for Abiraterone Acetate and Concomitant Prednisone Use in Patients with Prostate Cancer

BACKGROUND: With the growing use of oral anticancer medications, understanding adherence patterns has become increasingly important. Abiraterone acetate (AA) is a prodrug of abiraterone, a novel androgen biosynthesis inhibitor. AA is approved for use in combination with prednisone for treatment of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lafeuille, Marie-Hélène, Grittner, Amanda Melina, Lefebvre, Patrick, Ellis, Lorie, McKenzie, R. Scott, Slaton, Terra, Kozma, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437892/
https://www.ncbi.nlm.nih.gov/pubmed/24761819
http://dx.doi.org/10.18553/jmcp.2014.20.5.477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437892/
https://www.ncbi.nlm.nih.gov/pubmed/24761819
http://dx.doi.org/10.18553/jmcp.2014.20.5.477

Ejemplares similares